Plasma Cell-free Mitochondrial DNA Declines in Response to Prolonged Moderate Aerobic Exercise
Overview
Authors
Affiliations
Increased plasma cell-free mitochondrial DNA (cf-mDNA), a damage-associated molecular pattern (DAMP) produced by cellular injury, contributes to neutrophil activation/inflammation in trauma patients and arises in cancer and autoimmunity. To further understand relationships between cf-mDNA released by tissue injury, inflammation, and health benefits of exercise, we examined cf-mDNA response to prolonged moderate aerobic exercise. Seven healthy moderately trained young men (age = 22.4 ± 1.2) completed a treadmill exercise trial for 90 min at 60% VO2 max and a resting control trial. Blood was sampled immediately prior to exercise (0 min = baseline), during (+18, +54 min), immediately after (+90 min), and after recovery (R40). Plasma was analyzed for cf-mDNA, IL-6, and lactate. A significant difference in cf-mDNA response was observed between exercise and control trials, with cf-mDNA levels reduced during exercise at +54 and +90 (with or without plasma volume shift correction). Declines in cf-mDNA were accompanied by increased lactate and followed by an increase in IL-6, suggesting a temporal association with muscle stress and inflammatory processes. Our novel finding of cf-mDNA decline with prolonged moderate treadmill exercise provides evidence for increased clearance from or reduced release of cf-mDNA into the blood with prolonged exercise. These studies contrast with previous investigations involving exhaustive short-term treadmill exercise, in which no change in cf-mDNA levels were reported, and contribute to our understanding of differences between exercise- and trauma-induced inflammation. We propose that transient declines in cf-mDNA may induce health benefits, by reducing systemic inflammation.
Bondar G, Mahapatra A, Bao T, Silacheva I, Hairapetian A, Vu T J Clin Med. 2024; 13(11).
PMID: 38892912 PMC: 11172881. DOI: 10.3390/jcm13113200.
Chimienti G, Russo F, Bianco A, Maqoud F, De Virgilio C, Galeano G Int J Mol Sci. 2024; 25(8).
PMID: 38673878 PMC: 11050617. DOI: 10.3390/ijms25084293.
Michelson J, Rausser S, Peng A, Yu T, Sturm G, Trumpff C Mitochondrion. 2023; 71:26-39.
PMID: 37172669 PMC: 10524316. DOI: 10.1016/j.mito.2023.05.001.
Michelson J, Rausser S, Peng A, Yu T, Sturm G, Trumpff C bioRxiv. 2023; .
PMID: 36711938 PMC: 9882007. DOI: 10.1101/2023.01.04.522744.
Nabi S, Rehman M, Arafah A, Taifa S, Khan I, Khan A Curr Neuropharmacol. 2022; 21(5):1042-1064.
PMID: 36411568 PMC: 10286588. DOI: 10.2174/1570159X21666221121095618.